https://www.openbell.ai/ 2026-10-02T11:49:04.804Z hourly 1.0 https://www.openbell.ai/support 2026-10-02T11:49:04.804Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-02T11:49:04.804Z monthly 0.5 https://www.openbell.ai/terms 2026-10-02T11:49:04.804Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-02T11:49:04.804Z hourly 0.8 https://www.openbell.ai/news/GOOG:1790941732416 2026-10-02T11:48:52.416Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Turns Up AI Heat With Gemini 4 Argon, Rivals May Have to Cut Prices: Analyst Alphabet Inc. has launched its new AI model, Gemini 4 Argon, priced at $2 per million input tokens and $10 per million output tokens, with a 95% discount on cached input tokens. Analysts from BNP Paribas and Jefferies view this development positively, highlighting Google's competitive pricing, infrastructure, and ecosystem as key advantages. BNP Paribas has set a price target of $420 for Alphabet, indicating a 22% upside from its recent price of $344.10. The pricing strategy could pressure competitors to adjust their own pricing, potentially reshaping the AI market landscape. https://www.openbell.ai/news/HPE:1790941627266 2026-10-02T11:47:07.266Z daily 0.9 https://cdn.brandfetch.io/HPE/w/400/h/400?c=1idopYfmtR7ZKg8QMud This Hewlett Packard Enterprise Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Daiwa Capital analyst Louis Miscioscia upgraded Hewlett Packard Enterprise Co (NYSE: HPE) from Neutral to Outperform and raised the price target from $65 to $75, while the stock closed at $64.58 on Thursday. This upgrade is part of a broader trend where analysts are adjusting their ratings on various companies, reflecting changing market sentiments. https://www.openbell.ai/news/SCNX:1790941565130 2026-10-02T11:46:05.130Z daily 0.9 https://cdn.brandfetch.io/SCNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions Scienture Holdings Inc. (NASDAQ: SCNX) announced that three leading U.S. pediatric academic medical centers have added its hypertension medication, Arbli (losartan potassium) Oral Suspension, to their formularies. The company aims to expand its market penetration, leveraging high gross margins and increasing wholesale orders. Arbli addresses a significant U.S. losartan market, which generates approximately $219 million in annual sales. Despite this expansion, SCNX shares were down 0.34% at $0.17 during premarket trading, near its 52-week low. https://www.openbell.ai/news/SCNX:1790941535263 2026-10-02T11:45:35.263Z daily 0.9 https://cdn.brandfetch.io/SCNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Scienture Says Hypertension Drug Arbli Added To Formularies At Three US Pediatric Academic Medical Centers And Hospitals, Addressing Approximately 72M Prescriptions Annually openbell Financial News https://www.openbell.ai/news/SYNA:1790941188781 2026-10-02T11:39:48.781Z daily 0.9 https://cdn.brandfetch.io/SYNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Synaptics shares are trading higher after the company announced it will be acquired by onsemi for $123 per share under the revised agreement. openbell Financial News https://www.openbell.ai/news/VYLR:1790941111730 2026-10-02T11:38:31.730Z daily 0.9 https://cdn.brandfetch.io/VYLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vylor shares are trading higher after the company was added to the S&P 500. Also, Morgan Stanley and BMO Capital initiated coverage on the stock. openbell Financial News https://www.openbell.ai/news/GLPEY:1790941047289 2026-10-02T11:37:27.289Z daily 0.9 https://cdn.brandfetch.io/GLPEY/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Galp Said to Weigh Sale, Partner for Renewable Energy Assets' - Bloomberg Galp is reportedly considering the sale or partnership of its renewable energy assets as part of a strategic review. This move comes amid a broader focus on expanding its renewable portfolio. The company's stock, trading under the ticker GLPEY, may be impacted by these potential changes in asset management. https://www.openbell.ai/news/BTCUSD:1790941024409 2026-10-02T11:37:04.409Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Cryptocurrency-Coins-Displaying-XRP--Sol.jpg?width=250&height=187 Bitcoin, ETH, XRP Rally Over 2% as Funding Rates Triple: What's Going On? Bitcoin (BTC), Ethereum (ETH), and XRP have seen a rally of over 2% as derivatives traders increase bullish positions ahead of the U.S. jobs report. Bitcoin's open interest rose to approximately 653,000 BTC, valued at $56.2 billion, marking a 4.3% increase from the previous week. The perpetual funding rate surged from about 3% to 10%, indicating higher costs for holding long positions. Additionally, crypto-linked stocks such as Strategy (MSTR) and Strive (ASST) gained around 3% in premarket trading, while Coinbase (COIN) and Robinhood (HOOD) rose roughly 2%. https://www.openbell.ai/news/NKE:1790940930742 2026-10-02T11:35:30.742Z daily 0.9 https://cdn.brandfetch.io/NKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nike shares are trading lower after the company reported mixed Q1 financial results and issued FY27 adjusted EPS guidance below estimates. Multiple firms lowered their respective price targets on the stock. openbell Financial News https://www.openbell.ai/news/NKTR:1790940560742 2026-10-02T11:29:20.742Z daily 0.9 https://cdn.brandfetch.io/NKTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Nektar Therapeutics, Maintains $185 Price Target HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Nektar Therapeutics (NASDAQ: NKTR) and maintained a price target of $185 for the stock. https://www.openbell.ai/news/KBH:1790940278132 2026-10-02T11:24:38.132Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/President-Donald-J--Trump-Delivers-Remar.jpg?width=250&height=187 Trump Promised to Bring Mortgage Rates Down to 3% — Two Years Later, They Are at the Highest Since He Took Office: Economist Says 'I Would Be Extremely Concerned Right Now…' As of October 1, 2026, the average 30-year fixed mortgage rate has risen to 7.28%, the highest since Donald Trump took office in January 2025, up from 7.03% the previous week and 6.34% a year ago. Trump previously claimed that mortgage rates could fall to 3% or lower, a statement that has drawn criticism from figures such as Senator Mark Warner. Economists are concerned about the potential for rates to rise further, with some suggesting they could reach 9% in a severe scenario, while homebuilders are adapting to the current market conditions with various pricing strategies and incentives. https://www.openbell.ai/news/MAN:1790940127491 2026-10-02T11:22:07.491Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Analysts.jpg?width=250&height=187 ManpowerGroup Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ManpowerGroup Inc. (NYSE: MAN) is set to announce its Q3 earnings on October 15, with analysts predicting earnings of $1.01 per share, an increase from 83 cents per share in the same quarter last year. The expected revenue for the quarter is $4.85 billion, compared to $4.63 billion in the previous year. Following a positive Q2 earnings report, ManpowerGroup's shares rose 1.3% to close at $56.28. https://www.openbell.ai/news/MDB:1790939994127 2026-10-02T11:19:54.127Z daily 0.9 https://cdn.brandfetch.io/MDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Reiterates Overweight on MongoDB, Maintains $540 Price Target Cantor Fitzgerald analyst Thomas Blakey has reiterated an Overweight rating on MongoDB (NASDAQ: MDB) and maintained a price target of $540 for the stock. This indicates a positive outlook for the company's performance in the market. https://www.openbell.ai/news/CRWV:1790939856997 2026-10-02T11:17:36.997Z daily 0.9 https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Reiterates Overweight on CoreWeave, Maintains $176 Price Target Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on CoreWeave (NASDAQ: CRWV) and maintained a price target of $176 for the stock. This indicates a positive outlook for the company's performance in the market. https://www.openbell.ai/news/XPO:1790939378110 2026-10-02T11:09:38.110Z daily 0.9 https://cdn.brandfetch.io/XPO/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Maintains Buy on XPO, Raises Price Target to $230 B of A Securities analyst Ken Hoexter has maintained a Buy rating on XPO (NYSE: XPO) and raised the price target from $228 to $230. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/NKE:1790939294003 2026-10-02T11:08:14.003Z daily 0.9 https://cdn.brandfetch.io/NKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Maintains Underperform on Nike, Lowers Price Target to $24 B of A Securities analyst Lorraine Hutchinson has maintained an 'Underperform' rating on Nike (NYSE: NKE) and has lowered the price target from $30 to $24. https://www.openbell.ai/news/TFIN:1790939067521 2026-10-02T11:04:27.521Z daily 0.9 https://cdn.brandfetch.io/TFIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud B. Riley Securities Upgrades Triumph Financial to Buy, Maintains Price Target to $82 B. Riley Securities has upgraded Triumph Financial (NYSE: TFIN) from a Neutral rating to a Buy rating. The firm has maintained its price target for the stock at $82. https://www.openbell.ai/news/SSNGY:1790938798795 2026-10-02T10:59:58.795Z daily 0.9 https://cdn.brandfetch.io/SSNGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, 'Samsung to Triple HBM Prices Next Year' - MK Exclusive Samsung is set to triple the prices of its High Bandwidth Memory (HBM) starting next year, according to a report. This strategic move is expected to significantly impact the semiconductor market, potentially affecting pricing structures across the industry. The decision comes as Samsung aims to enhance its profitability in the competitive memory chip sector. https://www.openbell.ai/news/AVLN:1790938664250 2026-10-02T10:57:44.250Z daily 0.9 https://cdn.brandfetch.io/AVLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raymond James Initiates Coverage On Avalyn Pharma with Outperform Rating, Announces Price Target of $60 Raymond James analyst Tiago Fauth has initiated coverage on Avalyn Pharma (NASDAQ: AVLN) with an Outperform rating. The firm has set a price target of $60 for the company's stock. https://www.openbell.ai/news/SPIR:1790938637319 2026-10-02T10:57:17.319Z daily 0.9 https://cdn.brandfetch.io/SPIR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Spire Global Announces Successful Launch Of The First Three Satellites Built At Its Colorado Manufacturing Facility Spire Global successfully launched its first three satellites from its Colorado manufacturing facility aboard SpaceX’s Transporter-18 mission. This launch represents a significant operational milestone as Spire expands its U.S. manufacturing capabilities to address increasing national security demands. The Boulder facility allows for comprehensive satellite development and testing, enhancing the company's ability to deploy mission-specific space capabilities while ensuring supply chain security. https://www.openbell.ai/news/NVDA:1790938438232 2026-10-02T10:53:58.232Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Nvidia-CEO-Jensen-Huang-delivering-a-key.jpg?width=250&height=187 Michael Burry Just Pulled a 1960s Market Bubble Into Nvidia's AI Debate — ‘We Have All Been Here Before’ Michael Burry, known for his role in 'The Big Short', has drawn parallels between Nvidia Corp.'s (NASDAQ: NVDA) current market situation and the 1960s market bubble, particularly regarding its defense of graphics processing unit depreciation schedules. Nvidia's recent presentation suggested that its chips retain value beyond accelerated depreciation, which Burry argues reflects a speculative mindset reminiscent of past market frenzies. As of the latest trading data, NVDA stock is up 23.79% year-to-date, closing at $230.86, indicating a strong price trend. https://www.openbell.ai/news/ARTV:1790937985469 2026-10-02T10:46:25.469Z daily 0.9 https://cdn.brandfetch.io/ARTV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Reiterates Overweight on Artiva Biotherapeutics, Maintains $40 Price Target Cantor Fitzgerald analyst Josh Schimmer has reiterated an Overweight rating on Artiva Biotherapeutics (NASDAQ: ARTV) and maintained a price target of $40 for the company's stock. No specific financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/MU:1790937969583 2026-10-02T10:46:09.583Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Los-Angeles--California---24-January-202.jpg?width=250&height=187 Micron Analyst Dismisses Supply Glut Fears As AI Memory Crunch Deepens Micron Technology Inc. (NASDAQ: MU) is benefiting from a surge in memory demand driven by AI infrastructure, with the stock rising nearly 300% in 2026 amid a global supply shortage. Analysts, including Ben Reitzes from Melius Research, predict that the AI-driven memory cycle may extend into 2028, despite concerns about new supply potentially impacting pricing. Bank of America Securities' Vivek Arya emphasizes that AI demand is growing over 100% annually, outpacing the 40%-50% annual capacity expansion, which supports strong pricing power. Micron shares were up 0.87% to $1106.94 in premarket trading. https://www.openbell.ai/news/MAT:1790937954451 2026-10-02T10:45:54.451Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Mattel.jpg?width=250&height=187 Is Mattel Getting Bought Out? $6 Billion Authentic Brands Deal Rumor Triggers Massive Rally Mattel, Inc. (NASDAQ: MAT) stock surged over 18% on Thursday, reaching $15.10, amid rumors of a potential acquisition by Authentic Brands Group, which could value Mattel at over $6 billion. Reports indicate that Authentic Brands might offer more than $20 per share, a 58% premium to Mattel's previous closing price of $12.66. The discussions are still preliminary, and no formal offer has been made. Additionally, Mattel is undergoing a leadership transition, with CEO Ynon Kreiz stepping down on October 2, and Roger Lynch set to take over as chairman and CEO by November 2. https://www.openbell.ai/news/XOM:1790937954280 2026-10-02T10:45:54.280Z daily 0.9 https://cdn.brandfetch.io/XOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Exxon, Chevron Head Into Earnings With Venezuela, LNG and Higher Oil Prices in Focus ExxonMobil and Chevron are preparing to report their third-quarter earnings, with a focus on refining margins, crude prices, and geopolitical impacts. Chevron plans to invest over $7 billion in Venezuela to double its production to approximately 600,000 barrels per day, while ExxonMobil is advancing its Rovuma LNG project in Mozambique with $1.1 billion in pre-investment contracts. Analysts expect Exxon to report earnings of $3.40 per share, up from $1.88 a year earlier, and Chevron to report earnings of $4.32 per share, up from $1.85. Both companies are facing oil-market volatility and geopolitical disruptions that could affect their operations. https://www.openbell.ai/news/MAT:1790937943662 2026-10-02T10:45:43.662Z daily 0.9 https://cdn.brandfetch.io/MAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Is Mattel Getting Bought Out? $6 Billion Authentic Brands Deal Rumor Triggers Massive Rally Mattel, Inc. (NASDAQ: MAT) experienced a significant stock rally, surging over 18% on Thursday, following rumors that Authentic Brands Group is considering a buyout valued at over $6 billion. The potential offer could exceed $20 per share, representing a 58% premium to Mattel's previous closing price of $12.66. Additionally, Mattel is undergoing a leadership transition, with CEO Ynon Kreiz stepping down on October 2, and the company is expected to report earnings on October 20, with analysts forecasting EPS of $1.01 on revenue of $1.84 billion. https://www.openbell.ai/news/XOM:1790937943294 2026-10-02T10:45:43.294Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Oil-Pump-In-The-Desert-Of-Bahrain--Middl.jpg?width=250&height=187 Exxon, Chevron Head Into Earnings With Venezuela, LNG and Higher Oil Prices in Focus ExxonMobil and Chevron are preparing to report their third-quarter earnings on October 30, with analysts expecting Exxon to post earnings of $3.40 per share and revenue of $94.88 billion, while Chevron is projected to earn $4.32 per share with revenue of $54.94 billion. Chevron's significant developments include a $7 billion investment plan in Venezuela aimed at doubling production to 600,000 barrels per day, and a successful oil discovery in Angola. ExxonMobil is advancing its Rovuma LNG project in Mozambique with $1.1 billion in pre-investment contracts and expects to hold a 34.1% interest in the Papua LNG project in Papua New Guinea. Both companies are facing oil price volatility and geopolitical disruptions that could impact their operations. https://www.openbell.ai/news/RTX:1790937853576 2026-10-02T10:44:13.576Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Jakarta---June-12-2024-Rtx-Corporation-F.jpg?width=250&height=187 Rtx Adds $24.4 Billion SM-6 Contract To Recent Missile Award Run RTX Corporation's Raytheon business has secured a five-year contract worth up to $24.4 billion for the production of Standard Missile-6 interceptors, enhancing its missile capabilities. This contract follows a series of significant awards, including a $20.7 billion AMRAAM contract and a $22.9 billion Tomahawk missile deal. RTX shares rose 0.64% to $186.20 in premarket trading, although the stock remains below key moving averages and is considered oversold. The company is expected to report earnings on October 20, with analysts predicting an EPS of $1.77 on revenue of $24 billion. https://www.openbell.ai/news/BETR:1790937829345 2026-10-02T10:43:49.345Z daily 0.9 https://cdn.brandfetch.io/BETR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Upgrades Better Home & Finance to Overweight, Maintains Price Target to $16 Cantor Fitzgerald analyst Ramsey El-Assal has upgraded Better Home & Finance (NASDAQ: BETR) from Neutral to Overweight. The firm has maintained its price target for the stock at $16. https://www.openbell.ai/news/BA:1790937636880 2026-10-02T10:40:36.880Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Irving--Texas--Usa---March-20--2022-Clos.jpg?width=250&height=187 Boeing Dodges Strike That Could Have Hit 737 MAX 10, 777X Certification — Engineers' Union Approves New Deal Boeing Co. (NYSE: BA) has avoided a potential strike after the Society of Professional Engineering Employees in Aerospace (SPEEA) approved a new four-year contract, which includes a guaranteed 10% wage increase and annual raises of 4%, with possible additional performance-based pay. This agreement alleviates concerns regarding the certification processes for the 737 MAX 10 and 777X aircraft, which could have been disrupted by a work stoppage. Additionally, Boeing has recently faced delays in the 737 MAX 10 certification due to a software issue but has secured a $20 billion contract from the Pentagon for the development of the U.S. Navy’s next-generation stealth fighter. https://www.openbell.ai/news/HBNC:1790937492483 2026-10-02T10:38:12.483Z daily 0.9 https://cdn.brandfetch.io/HBNC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Upgrades Horizon Bancorp to Overweight, Raises Price Target to $24 Piper Sandler analyst Nathan Race has upgraded Horizon Bancorp (NASDAQ: HBNC) from Neutral to Overweight. The price target for the stock has been raised from $23 to $24. https://www.openbell.ai/news/EQBK:1790937376651 2026-10-02T10:36:16.651Z daily 0.9 https://cdn.brandfetch.io/EQBK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Downgrades Equity Bancshares to Neutral, Lowers Price Target to $52 Piper Sandler analyst Nathan Race has downgraded Equity Bancshares (NYSE: EQBK) from Overweight to Neutral. The firm has also reduced its price target for the stock from $60 to $52. https://www.openbell.ai/news/STTK:1790937304501 2026-10-02T10:35:04.501Z daily 0.9 https://cdn.brandfetch.io/STTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Maintains Buy on Shattuck Labs, Raises Price Target to $19 Needham analyst Joseph Stringer has maintained a 'Buy' rating on Shattuck Labs (NASDAQ: STTK) and raised the price target from $17 to $19. https://www.openbell.ai/news/BUSE:1790937208111 2026-10-02T10:33:28.111Z daily 0.9 https://cdn.brandfetch.io/BUSE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Downgrades First Busey to Neutral, Lowers Price Target to $30 Piper Sandler analyst Nathan Race has downgraded First Busey (NASDAQ: BUSE) from Overweight to Neutral. The price target has been reduced from $35 to $30. https://www.openbell.ai/news/STT:1790937169776 2026-10-02T10:32:49.776Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/State-Street-Photo-by-JHVEPhoto-via-Shut.jpg?width=250&height=187 State Street Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts State Street Corporation (NYSE: STT) is set to release its Q3 earnings on October 14, with analysts forecasting earnings of $3.66 per share, an increase from $2.78 per share in the same period last year. The expected quarterly revenue is $4.04 billion, up from $3.54 billion reported last year. Following a better-than-expected Q2 report, State Street's shares rose 0.6% to close at $174.62. Recent analyst ratings have seen price targets raised by several firms, with Keefe, Bruyette & Woods setting the highest target at $215. https://www.openbell.ai/news/CGEM:1790937165244 2026-10-02T10:32:45.244Z daily 0.9 https://cdn.brandfetch.io/CGEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Cullinan Therapeutics, Maintains $35 Price Target HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Cullinan Therapeutics (NASDAQ: CGEM) and maintained a price target of $35 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/ALRS:1790937103710 2026-10-02T10:31:43.710Z daily 0.9 https://cdn.brandfetch.io/ALRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Upgrades Alerus Financial to Overweight, Raises Price Target to $38 Piper Sandler has upgraded Alerus Financial (NASDAQ: ALRS) from Neutral to Overweight. The firm has also raised its price target for the stock from $37 to $38. https://www.openbell.ai/news/APC:1790936997020 2026-10-02T10:29:57.020Z daily 0.9 https://cdn.brandfetch.io/APC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Upgrades Arko Petroleum to Outperform, Maintains Price Target to $22 Mizuho analyst Gabriel Moreen has upgraded Arko Petroleum (NASDAQ: APC) from Neutral to Outperform. The price target for the stock remains unchanged at $22. https://www.openbell.ai/news/CNTB:1790936940041 2026-10-02T10:29:00.041Z daily 0.9 https://cdn.brandfetch.io/CNTB/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target HC Wainwright & Co. analyst Brandon Folkes has reiterated a 'Buy' rating on Connect Biopharma Holdings (NASDAQ: CNTB) and maintained a price target of $7 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/LYTS:1790936747735 2026-10-02T10:25:47.735Z daily 0.9 https://cdn.brandfetch.io/LYTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on LSI Industries, Maintains $30 Price Target HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating on LSI Industries (NASDAQ: LYTS) and maintained a price target of $30 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/ARKK:1790936435631 2026-10-02T10:20:35.631Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Kalshi-Logo-On-Smartphone-Screen.jpg?width=250&height=187 Cathie Wood Praises Kalshi's 'Phenomenal' Leadership as ARK Bets on $5 Trillion Prediction Market Opportunity: 'Skating to Where the… Puck Will Be' Cathie Wood, CEO of Ark Invest, has praised Kalshi Inc.'s leadership, highlighting its potential in the prediction market sector, which Ark estimates could reach an annual notional volume of $1 trillion to $5 trillion. Ark recently acquired a total of 126,594 shares of Kalshi across three of its ETFs, including the ARK Innovation ETF, which holds $5.56 billion in assets. Despite acknowledging risks such as legal challenges and competition, Ark believes the upside of investing in Kalshi outweighs these concerns. https://www.openbell.ai/news/TTAN:1790936407712 2026-10-02T10:20:07.712Z daily 0.9 https://cdn.brandfetch.io/TTAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on ServiceTitan, Maintains $110 Price Target BTIG analyst Nick Altmann has reiterated a Buy rating on ServiceTitan (NASDAQ: TTAN) and has maintained a price target of $110 for the stock. This endorsement reflects confidence in the company's performance and market position. https://www.openbell.ai/news/SUJA:1790936027879 2026-10-02T10:13:47.879Z daily 0.9 https://cdn.brandfetch.io/SUJA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Initiates Coverage On Suja Life with Buy Rating, Announces Price Target of $20 Roth Capital analyst Sean McGowan has initiated coverage on Suja Life (NASDAQ: SUJA) with a Buy rating. The firm has set a price target of $20 for the company's stock. https://www.openbell.ai/news/MU:1790935973724 2026-10-02T10:12:53.724Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Los-Angeles--California---24-January-202.jpg?width=250&height=187 Micron Analyst Dismisses Supply Glut Fears As AI Memory Crunch Deepens Micron Technology Inc. (NASDAQ: MU) has seen a significant boost from the AI infrastructure boom, with its stock rising nearly 300% in 2026 due to high memory demand and constrained supply. Analysts predict a prolonged AI-driven memory cycle, with Melius Research's Ben Reitzes suggesting that supply-demand conditions may remain tight even into 2028. Bank of America Securities' Vivek Arya estimates that AI-related demand is increasing over 100% annually, while semiconductor capacity grows only 40-50% per year, supporting strong pricing power. Micron shares were up 0.87% to $1106.94 in premarket trading. https://www.openbell.ai/news/ABNB:1790935769650 2026-10-02T10:09:29.650Z daily 0.9 https://cdn.brandfetch.io/ABNB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Keybanc Upgrades Airbnb to Overweight, Announces $191 Price Target Keybanc analyst Sergio Segura has upgraded Airbnb (NASDAQ: ABNB) from Sector Weight to Overweight, setting a price target of $191 for the stock. This upgrade reflects a positive outlook on the company's performance in the market. https://www.openbell.ai/news/SSM:1790935617764 2026-10-02T10:06:57.764Z daily 0.9 https://cdn.brandfetch.io/SSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sono Group Shares Up 13% Premarket; Alpine Fox Capital Reported A 21.5 % Stake In A 13D Filing On Thursday openbell Financial News https://www.openbell.ai/news/ENSG:1790935616273 2026-10-02T10:06:56.273Z daily 0.9 https://cdn.brandfetch.io/ENSG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ensign Group Expands In Colorado, Florida And Washington With The Acquisition Of 19 Separate Facilities; Terms Not Disclosed Ensign Group, Inc. has expanded its operations by acquiring 19 facilities across Colorado, Florida, and Washington, although the financial terms of the transactions were not disclosed. The acquisitions include four skilled nursing facilities in Washington, eight facilities in Florida with a total of 713 skilled nursing beds and 66 independent living units, and seven facilities in Colorado comprising 760 skilled nursing beds and 47 independent living units. With these additions, Ensign's portfolio now includes 418 healthcare operations across 18 states, and the company continues to seek further acquisition opportunities in the healthcare sector. https://www.openbell.ai/news/JNJ:1790935395658 2026-10-02T10:03:15.658Z daily 0.9 https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson & Johnson Announces Two-year Data From Its Phase 3 ICONIC-TOTAL Study Of ICOTYDE On High-Impact Plaque Psoriasis Sites; 60% Of Patients With Scalp Psoriasis And 89% With Genital Psoriasis Achieved Site-Specific Complete Skin Clearance At Week 112 Johnson & Johnson presented two-year data from its Phase 3 ICONIC-TOTAL study of ICOTYDE for treating high-impact plaque psoriasis at the EADV Congress 2026. The study showed that 60% of patients with scalp psoriasis and 89% with genital psoriasis achieved complete skin clearance at Week 112. Additionally, the overall rate of clear or almost clear skin increased from 57% at Week 16 to 70% at Week 112. The safety profile of ICOTYDE remained consistent with previous findings, with no new safety signals identified. https://www.openbell.ai/news/AMZN:1790935240998 2026-10-02T10:00:40.998Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Houston--Texas--Usa---April-13--2024-Clo.jpg?width=250&height=187 Amazon Eyes $8 Billion Nvidia Chip Sale to Investors as AI Infrastructure Costs Surge: Report Amazon.com Inc. is reportedly looking to transfer approximately $8 billion worth of Nvidia AI chips to outside investors through a special-purpose vehicle, aiming to make its balance sheet more asset-light. The proposed structure would allow Amazon to lease the chips back while potentially offering investors an equity stake of up to 10%. In related news, Amazon has raised its 2026 capital spending target by $20 billion to $220 billion due to rising memory chip prices and strong demand for AI infrastructure. https://www.openbell.ai/news/ENB:1790935130836 2026-10-02T09:58:50.836Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/02/Nvidia--Nokia--Bloom-Energy--Visa-And-Ca.jpg?width=250&height=187 Top 3 Energy Stocks That May Rocket Higher This Quarter The article highlights three energy stocks that are currently considered oversold, presenting potential buying opportunities. Enbridge Inc. (NYSE: ENB) has an RSI of 26 and a recent price target of $50 from Goldman Sachs, with shares closing at $46.27. National Energy Services Reunited Corp (NASDAQ: NESR) has an RSI of 23.9, with shares down to $24.94 and a lowered price target of $46 from UBS. WaterBridge Infrastructure LLC (NYSE: WBI) has an RSI of 29.9, with shares closing at $28.13 and a price target of $37 from Piper Sandler.